ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,164.12
-0.19%
Dow Jones
39,118.86
-0.12%
Gold vs US Dollar
2,323.525
-0.08%
Brent Oil
85.025
-0.10%
Bitcoin
62,762.99
0.15%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Summit Therapeutics Inc (SMMT) Share Price

SMMT Summit Therapeutics Inc

0.00
0.00 (0.00%)
- - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Summit Therapeutics Inc NASDAQ:SMMT NASDAQ Depository Receipt  ADS
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.00 0.00 0.00 0.00 0.00 0.00 0.00      
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 1M -614.93M -0.8760 -8.85 5.44B
 Type  Size  Price  Time  Units 
   0.00  
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore SMMT News
27/06/202421:15BWSummit Therapeutics Appoints Jeff Huber, Transformational Google and GRAIL Executive, to its Board of Directors
18/06/202422:14EDGAR2Form D - Notice of Exempt Offering of Securities
17/06/202422:25EDGAR2Form 8-K - Current report
13/06/202419:03EDGAR2Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
03/06/202411:18EDGAR2Form 8-K - Current report
03/06/202411:05EDGAR2Form 8-K - Current report
03/06/202410:30BWSummit Raises $200 Million; Also Expands License Territories for Ivonescimab
Period
Draw mode
Data Downloads for SMMT

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Summit Therapeutics Inc Articles